Retraction
Clinical trials in Alzheimer's disease': immunotherapy approaches
Paper Information
Record ID:
30541
Journal:
Publication Date:
August 30, 2011
Retraction Date:
July 06, 2021
(4.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Alzheimer’s Disease Clinical Research Centre, Gérontopôle, Toulouse University Hospital, FranceCountry:
🇫🇷 FranceArticle Type:
Publisher:
Wiley
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (145)
145
Total Citations6
Post-Retraction(4.1%)
138
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
5
After 2+ years
1061
Days since retraction (latest)
Amyloid Chemical Probes and Theranostics: Steps Toward Personalized Medicine in Neurodegenerative Diseases
María Laura Bolognesi
Methods and principles in medicinal chemistry
Published: Dec 2013
5 citations
5 citations
2762 days before retraction
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Nevena Djogo
Unknown Journal
Published: Dec 2013
2765 days before retraction
Monoclonal Antibodies in Therapeutics
Somesh Rayasam, Sujata Dudhgaonkar, Prashant K. Deshmukh et al. (6 authors)
Asian journal of biomedical and pharmaceutical sciences
Published: Dec 2013
2 citations
2 citations
2770 days before retraction
Farmakoterapia dysfunkcji poznawczych w chorobie Alzheimera: obecne strategie i terapie eksperymentalne
Tomasz Sobów
DOAJ (DOAJ: Directory of Open Access Journals)
Published: Dec 2013
2774 days before retraction
Hippocampal Glutamate NMDA Receptor Loss Tracks Progression in Alzheimer’s Disease: Quantitative Autoradiography in Postmortem Human Brain
Efrat Kravitz, Inna Gaisler‐Salomon, Anat Biegon
PLoS ONE
Open Access
Published: Nov 2013
27 citations
27 citations
2777 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Nov 2013
2791 days before retraction
Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease
Marybeth Camboni, Chiou-Miin Wang, Carlos J. Miranda et al. (8 authors)
Neurobiology of Disease
Open Access
Published: Sep 2013
6 citations
6 citations
2858 days before retraction
Alzheimer's disease and immunotherapy.
Jennifer Madeo, Marianne Frieri
PubMed
Published: Aug 2013
13 citations
13 citations
2896 days before retraction
Epitope‐based DNA vaccine for Alzheimer's disease: Translational study in macaques
Claire F. Evans, Hayk Davtyan, Irina Petrushina et al. (9 authors)
Alzheimer s & Dementia
Open Access
Published: Jul 2013
47 citations
47 citations
2897 days before retraction
Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in <scp>APP</scp>swe/<scp>PS</scp>1dE9 Transgenic Mice
Jian‐Quan Shi, Bian‐Rong Wang, You‐Yong Tian et al. (9 authors)
CNS Neuroscience & Therapeutics
Open Access
Published: Jul 2013
103 citations
103 citations
2901 days before retraction
Genetic and Environmental Influences on Intellectual Disability in Childhood
Michèle Carlier, Pierre L. Roubertoux
Springer eBooks
Published: Jul 2013
10 citations
10 citations
2920 days before retraction
Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency
Geovanny Rivera-Hernández, Marta Marin‐Argany, Bernat Blasco-Moreno et al. (6 authors)
mAbs
Open Access
Published: Jul 2013
17 citations
17 citations
2927 days before retraction
Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant
Yun‐Zhou Yu, Shuang Wang, Bai Jie-ying et al. (12 authors)
Clinical Immunology
Published: Jun 2013
12 citations
12 citations
2953 days before retraction
Emerging Therapeutic Strategies in Alzheimer's Disease
Tomohiro Chiba
Neurodegenerative Diseases
Open Access
Published: May 2013
5 citations
5 citations
2974 days before retraction
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Thomas A. Bayer
European Neuropsychopharmacology
Published: May 2013
119 citations
119 citations
2988 days before retraction
Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
Teresa J. Broering, Hongyan Wang, Naomi K. Boatright et al. (13 authors)
PLoS ONE
Open Access
Published: Apr 2013
18 citations
18 citations
3002 days before retraction
Developing Therapeutic Antibodies for Neurodegenerative Disease
Y. Joy Yu, Ryan J. Watts
Neurotherapeutics
Open Access
Published: Apr 2013
185 citations
185 citations
3017 days before retraction
From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein
Jean‐Noël Octave, Nathalie Pierrot, Susana Ferrão Santos et al. (5 authors)
Journal of Neurochemistry
Published: Mar 2013
49 citations
49 citations
3033 days before retraction
Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
Hayk Davtyan, Anahit Ghochikyan, Irina Petrushina et al. (17 authors)
Journal of Neuroscience
Open Access
Published: Mar 2013
108 citations
108 citations
3037 days before retraction
Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease
Greetje Vanhoutte, Sandra Pereson, Rafael Delgado y Palacios et al. (10 authors)
Magnetic Resonance in Medicine
Published: Mar 2013
50 citations
50 citations
3039 days before retraction
Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
Kaan E. Biron, Dara L. Dickstein, Rayshad Gopaul et al. (5 authors)
Scientific Reports
Open Access
Published: Feb 2013
33 citations
33 citations
3050 days before retraction
Potential Therapeutic Strategies to Prevent the Progression of Alzheimer to Disease States
Ester Aso, Isidró Ferrer
InTech eBooks
Open Access
Published: Feb 2013
4 citations
4 citations
3051 days before retraction
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs
Journal of Alzheimer s Disease
Published: Feb 2013
27 citations
27 citations
3072 days before retraction
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Elvira Valera, Eliezer Masliah
Pharmacology & Therapeutics
Open Access
Published: Feb 2013
123 citations
123 citations
3074 days before retraction
Amyloid β inhibits retinoic acid synthesis exacerbating <scp>A</scp>lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
Maria B. Goncalves, Earl E. Clarke, Carl Hobbs et al. (7 authors)
European Journal of Neuroscience
Open Access
Published: Feb 2013
75 citations
75 citations
3074 days before retraction
Oligomeric amyloid-beta as a potential biomarker for Alzheimer's disease
Lalitha Venkataraman
Unknown Journal
Published: Jan 2013
3108 days before retraction
Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease
Benoît Leclerc, Abedelnasser Abulrob
The Scientific World JOURNAL
Open Access
Published: Jan 2013
18 citations
18 citations
3108 days before retraction
Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry
Richard McClure, Chad W. Chumbley, Michelle L. Reyzer et al. (7 authors)
NeuroImage Clinical
Open Access
Published: Jan 2013
22 citations
22 citations
3108 days before retraction
The Role of Oxidative Stress in Alzheimer ’ s Disease
Jennifer Madeo
Journal of Alzheimer’s Disease & Parkinsonism
Open Access
Published: Jan 2013
39 citations
39 citations
3108 days before retraction
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET
Paul Edison, Stephen F. Carter, Juha O. Rinne et al. (8 authors)
NeuroImage
Published: Dec 2012
59 citations
59 citations
3120 days before retraction
Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
Kie Honjo, Sandra E. Black, Nicolaas P. L. G. Verhoeff
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Open Access
Published: Nov 2012
149 citations
149 citations
3169 days before retraction
Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
Dominic Holland, Linda K. McEvoy, Rahul S. Desikan et al. (4 authors)
PLoS ONE
Open Access
Published: Oct 2012
67 citations
67 citations
3184 days before retraction
Is the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Andrew F. Teich, Ottavio Arancio
Biochemical Journal
Open Access
Published: Aug 2012
99 citations
99 citations
3248 days before retraction
Tau as a therapeutic target in neurodegenerative disease
Diana S. Himmelstein, Sarah Ward, Jody K. Lancia et al. (5 authors)
Pharmacology & Therapeutics
Open Access
Published: Jul 2012
107 citations
107 citations
3283 days before retraction
Rational heterodoxy: Cholesterol reformation of the amyloid doctrine
Michael A. Castello, Salvador Soriano
Ageing Research Reviews
Open Access
Published: Jul 2012
40 citations
40 citations
3287 days before retraction
Nuclear Factor-κB Regulates βAPP and β- and γ-Secretases Differently at Physiological and Supraphysiological Aβ Concentrations
L. Chami, Virginie Buggia-Prévot, Eric Duplan et al. (7 authors)
Journal of Biological Chemistry
Open Access
Published: Jun 2012
112 citations
112 citations
3322 days before retraction
Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
Marta Di Carlo, Daniela Giacomazza, Pier Luigi San Biagio
Journal of Physics Condensed Matter
Published: May 2012
62 citations
62 citations
3336 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: May 2012
3344 days before retraction
Paper citing Passive Immunization Reduces Behavioral and Neurop...
Unknown Authors
Unknown Journal
Published: Apr 2012
3360 days before retraction
Presenilin signalling in a basic biomedical model
Marthe Helene Regina Ludtmann
Unknown Journal
Published: Jan 2012
3474 days before retraction
Alternative Strategy for Alzheimer’s Disease: Stress Response Triggers
Joan Smith Sonneborn
International Journal of Alzheimer s Disease
Open Access
Published: Jan 2012
7 citations
7 citations
3474 days before retraction
Neuroprotection and Neuroregeneration in Alzheimer's Disease
Kimio Sugaya, Moussa B. H. Youdim, Agneta Nordberg et al. (4 authors)
International Journal of Alzheimer s Disease
Open Access
Published: Jan 2012
2 citations
2 citations
3474 days before retraction
Translational neuroimaging : tools for CNS drug discovery, development and treatment
Robert A. McArthur
Academic Press eBooks
Published: Jan 2012
9 citations
9 citations
3474 days before retraction
The future of Alzheimer's disease: The next 10 years
Harald Hampel, David Prvulovic, Stefan Teipel et al. (12 authors)
Progress in Neurobiology
Published: Nov 2011
226 citations
226 citations
3514 days before retraction
Quick Stats
Total Citations:
145
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025